APA (7th ed.) Citation

Moon, D., Hur, S., Lee, S., Jeong, M. H., Cho, K. H., Kwon, O., . . . Yoo, K. D. (2025). Real-World Safety and Effectiveness of Evolocumab in Korean Patients with Atherosclerotic Cardiovascular Disease or Familial Hypercholesterolemia: A Post-Marketing Surveillance Study. Cardiology & Therapy, 14(4), 619. https://doi.org/10.1007/s40119-025-00430-8

Chicago Style (17th ed.) Citation

Moon, Donggyu, Seung-Ho Hur, Sang-Rok Lee, Myung Ho Jeong, Kyung Hoon Cho, Osung Kwon, JinSeon Jeong, and Ki Dong Yoo. "Real-World Safety and Effectiveness of Evolocumab in Korean Patients with Atherosclerotic Cardiovascular Disease or Familial Hypercholesterolemia: A Post-Marketing Surveillance Study." Cardiology & Therapy 14, no. 4 (2025): 619. https://doi.org/10.1007/s40119-025-00430-8.

MLA (9th ed.) Citation

Moon, Donggyu, et al. "Real-World Safety and Effectiveness of Evolocumab in Korean Patients with Atherosclerotic Cardiovascular Disease or Familial Hypercholesterolemia: A Post-Marketing Surveillance Study." Cardiology & Therapy, vol. 14, no. 4, 2025, p. 619, https://doi.org/10.1007/s40119-025-00430-8.